Onkologie · 2010 · 31 citations · 4 references
Life SciencesOncologyPathologyApoptosisMolecular OncologyNeoplasiaApoptosis In CancerApoptotic Signal TransductionApoptotic SignalingEndometrial CancerExtrinsic Apoptotic PathwayUterine PathologyApoptotic ResponseCell Cycle Arrest SignalingClinicopathological CorrelationEndometrioid NeoplasmsLymph Node Metastasis Biomarkers
BACKGROUND: Apoptosis-stimulating protein of p53 (ASPP) family members can stimulate the apoptotic function of p53 but have no impact on its cell cycle arrest function. MATERIAL AND METHODS: The expression pattern of the ASPP family consisting of ASPP1, ASPP2, and iASPP was examined by immunohistochemistry in 45 formalin-fixed and paraffin-embedded endometrial endometrioid adenocarcinoma (EEA) specimens and 26 normal endometrial tissue (NET) samples. RESULTS: The expression rates of ASPP1 and ASPP2 in EEA were significantly lower than those in NET (p < 0.05). However, the iASPP expression rate in EEA was statistically higher in contrast to NET (p < 0.05). Expression of ASPP1 and iASPP in EEA had no correlation with any clinicopathological features (p > 0.05). iASPP was associated with grade, invasion, and lymph node metastasis (p < 0.05). CONCLUSIONS: It is a novel finding that the expression pattern of the ASPP family members has respective pathological and clinical implications in EEA, and iASPP might be a candidate target for EEA therapy.
4
iASPP oncoprotein is a key inhibitor of p53 conserved from worm to human
Daniele Bergamaschi, Yardena Samuels, Nigel J. O’Neil et al. · Nature Genetics · 2003 · 374 citations
Shrikesh Sachdev, Alexander Hoffmann, Mark Hannink · Molecular and Cellular Biology · 1998 · 140 citations · Full text